How I Treat Relapsed AML: Do Molecular Genetics Help?
Upon viewing this session, you will be able to identify the prognostic factors which predict outcome of patients with relapsed AML, recognize the importance of molecular genetics in treating patients with relapsed AML, and develop an approach for the treatment of patients with relapsed AML.
Martin S. Tallman, MD, Memorial Sloan-Kettering Cancer Center
Active, International, Emeritus, and Honorary Members
Associate, International Associate, Student, and Resident Members